CU20180048A7 - Método para inactivar xenoantígenos en tejidos biológicos - Google Patents

Método para inactivar xenoantígenos en tejidos biológicos

Info

Publication number
CU20180048A7
CU20180048A7 CU2018000048A CU20180048A CU20180048A7 CU 20180048 A7 CU20180048 A7 CU 20180048A7 CU 2018000048 A CU2018000048 A CU 2018000048A CU 20180048 A CU20180048 A CU 20180048A CU 20180048 A7 CU20180048 A7 CU 20180048A7
Authority
CU
Cuba
Prior art keywords
tissues
xenoantigins
inactivating
biological
treated
Prior art date
Application number
CU2018000048A
Other languages
English (en)
Other versions
CU24631B1 (es
Inventor
Alessandro Gandaglia
Filippo Naso
Original Assignee
Biocompatibility Innovation Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocompatibility Innovation Srl filed Critical Biocompatibility Innovation Srl
Publication of CU20180048A7 publication Critical patent/CU20180048A7/es
Publication of CU24631B1 publication Critical patent/CU24631B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625—Vascular tissue, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Prostheses (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

<p>Un método para inactivar xenoantígenos en tejidos biológicos, particularmente en tejidos que se pueden usar para fabricar sustitutos bioprotésicos y/o en sustitutos bioprotésicos que ya están preparados y destinados para uso clínico humano o veterinario.<br /> Tal método implica las siguientes etapas: proporcionar una solución basada en compuestos fenólicos, compuestos polifenólicos o derivados de los mismos, para la inactivación de al menos parte de los epitopos xenogénicos de dichos tejidos; incubar las muestras a ser tratadas en las diversas soluciones basadas en fenoles/polifenoles en condiciones controladas; someter los tejidos tratados a una serie de lavados.</p>
CU2018000048A 2015-11-30 2016-11-25 Método para inactivar xenoantígenos en tejidos biológicos CU24631B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB2015A006019A ITUB20156019A1 (it) 2015-11-30 2015-11-30 Metodo per l'inattivazione di xenoantigeni in tessuti biologici
PCT/EP2016/078898 WO2017093147A1 (en) 2015-11-30 2016-11-25 Method for inactivating xenoantigens in biological tissues

Publications (2)

Publication Number Publication Date
CU20180048A7 true CU20180048A7 (es) 2018-11-06
CU24631B1 CU24631B1 (es) 2022-12-12

Family

ID=55485194

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2018000048A CU24631B1 (es) 2015-11-30 2016-11-25 Método para inactivar xenoantígenos en tejidos biológicos

Country Status (18)

Country Link
US (1) US12589186B2 (es)
EP (1) EP3383446B1 (es)
JP (1) JP7169645B2 (es)
KR (1) KR20180090816A (es)
CN (1) CN108367098B (es)
AU (1) AU2016363536B2 (es)
BR (1) BR112018011021B1 (es)
CU (1) CU24631B1 (es)
DK (1) DK3383446T3 (es)
ES (1) ES2881603T3 (es)
IL (1) IL259591B (es)
IT (1) ITUB20156019A1 (es)
MX (1) MX385515B (es)
PL (1) PL3383446T3 (es)
RS (1) RS62100B1 (es)
RU (1) RU2754197C2 (es)
WO (1) WO2017093147A1 (es)
ZA (1) ZA201803786B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201600115523A1 (it) * 2016-11-16 2018-05-16 Biocompatibility Innovation Srl Metodo per l'inattivazione ed il controllo di avvenuta inattivazione di xenoantigeni in alimenti di origine animale, particolarmente per latte e derivati, e in alimenti di origine vegetale, particolarmente per succedanei di latte a base di soia e/o riso
WO2020234845A1 (en) 2019-05-22 2020-11-26 Biocompatibility Innovation Srl Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices
WO2024189407A1 (en) 2023-03-14 2024-09-19 Biocompatibility Innovation S.r.l. A method for imparting antimicrobial properties to a synthetic substrate
WO2025257595A1 (en) 2024-06-12 2025-12-18 Biocompatibility Innovation S.r.l. Preserving solution

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE408417T1 (de) * 2000-01-25 2008-10-15 Univ Nebraska Für die transplantation präparierte organe und abstossungsresistenz
US20040153145A1 (en) * 2002-11-26 2004-08-05 Clemson University Fixation method for bioprostheses
JP2007529278A (ja) * 2004-03-17 2007-10-25 レビビコア， インコーポレイテッド 機能的α１，３ガラクトシルトランスフェラーゼを欠く動物に由来する組織生成物
CA2627498C (en) * 2005-11-10 2013-06-11 Hill's Pet Nutrition, Inc. Compositions and methods for improving skin health and pelage quality
WO2007133479A2 (en) * 2006-05-10 2007-11-22 Cook Incorporated Delivery of elastin-stabilizing compound within a body lumen
CN101366979B (zh) * 2008-09-03 2012-08-29 陕西瑞盛生物科技有限公司 一种组织补片及其制备方法
FR2947456B1 (fr) * 2009-07-06 2012-03-09 Univ Bordeaux 1 Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain
IL210162A0 (en) * 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
US9937255B2 (en) * 2011-05-18 2018-04-10 Nectero Medical, Inc. Coated balloons for blood vessel stabilization
RU2495928C2 (ru) * 2012-01-30 2013-10-20 Сергей Юрьевич Лешков Средство для стимуляции синтеза белков теплового шока hsp 70 в клетках человека и животных; косметическое средство для стимуляции репаративных процессов; косметическое средство для снижения побочных эффектов агрессивных косметологических процедур; биологически активная добавка; пищевой продукт; способ снижения побочных эффектов агрессивных косметологических процедур
ITPD20120029A1 (it) 2012-02-09 2013-08-10 Alessandro Gandaglia Metodo per la rilevazione di uno xenoantigene in tessuti fissati usati come sostituti bioprotesici
US9283241B2 (en) * 2012-07-10 2016-03-15 Clemson University Treatment to render implants resistant to diabetes
US9795573B2 (en) * 2013-09-24 2017-10-24 Clemson University Multi-step connective tissue stabilization method and stabilized tissue formed thereby
US11951078B2 (en) * 2019-05-22 2024-04-09 Biocompatibility Innovation S.r.l. Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices

Also Published As

Publication number Publication date
US12589186B2 (en) 2026-03-31
AU2016363536B2 (en) 2021-04-01
BR112018011021B1 (pt) 2021-12-07
RU2018123621A (ru) 2020-01-09
RS62100B1 (sr) 2021-08-31
JP7169645B2 (ja) 2022-11-11
ITUB20156019A1 (it) 2017-05-30
CN108367098B (zh) 2021-06-11
AU2016363536A1 (en) 2018-06-28
IL259591A (en) 2018-07-31
EP3383446B1 (en) 2021-04-28
KR20180090816A (ko) 2018-08-13
US20180353647A1 (en) 2018-12-13
DK3383446T3 (da) 2021-07-26
BR112018011021A2 (pt) 2018-11-21
MX2018006577A (es) 2018-09-05
ES2881603T3 (es) 2021-11-30
IL259591B (en) 2022-04-01
WO2017093147A1 (en) 2017-06-08
CU24631B1 (es) 2022-12-12
CA3006234A1 (en) 2017-06-08
EP3383446A1 (en) 2018-10-10
JP2019503821A (ja) 2019-02-14
CN108367098A (zh) 2018-08-03
RU2018123621A3 (es) 2020-04-10
MX385515B (es) 2025-03-18
PL3383446T3 (pl) 2021-11-02
RU2754197C2 (ru) 2021-08-30
ZA201803786B (en) 2019-02-27

Similar Documents

Publication Publication Date Title
ECSP20046463A (es) Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas
CO2021005884A2 (es) Moduladores de la alfa-1 antitripsina
MX2018011348A (es) Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades.
ECSP19072372A (es) Moduladores de la expresión de pcsk9
CO2017001035A2 (es) “2-(morfolin-4-il)-1,7-naftiridinas sustituidas, composiciones y combinaciones farmacéuticas que las comprenden, y compuestos intermediarios
ECSP21026021A (es) Moduladores de la expresión de pnpla3
MX2021014709A (es) Composiciones para usarse en el incremento de los niveles de globulos rojos y el tratamiento de enfermedad de celulas falciformes.
ECSP10010548A (es) Composiciones y metodos de preparacion y uso de las mismas
MX2016002077A (es) Inhibidores de la proteína regulada por glucosa 94 (gpr94) selectivos y usos de los mismos.
CL2009000600A1 (es) Uso de compuestos de diaminopirimidina como agentes fitosanitarios; compuestos de diaminopirimidina; su procedimiento de preparacion; agente que los contiene; procedimiento para la preparacion de dicho agente; y procedimiento para combatir plagas de animales y/u hongos dañinos patogenos de plantas.
CL2018000596A1 (es) Nuevos compuestos bicíclicos como inhibidores de la atx
ECSP20082339A (es) Moduladores de la expresión de apol1
MX2018006577A (es) Metodo para inactivar xenoantigenos en tejidos biologicos.
CL2015002171A1 (es) Métodos de tratamiento de la dificiencia de hierro con pirofosfato férrico soluble.
BR112018009745A8 (pt) compostos heterocíclicos para o tratamento de doença
MX2017015293A (es) Composicion para tratar lesiones tisulares.
BR112015017837A2 (pt) composições e métodos para tratar cabelo danificado
CO2017011472A2 (es) Métodos de tratamiento de plantas de cultivo
CL2013000332A1 (es) Matriz impregnable de origen vegetal, animal o sintetica que contiene un compuesto antimicrobiano distribuido homogeneamente; procedimiento para impregnar un compuesto en una matriz; uso de dicha matriz para preparar soportes solidos de uso cosmetico, farmaceutico, medico o veterinario.
CL2019003172A1 (es) Brimonidina destinada al uso y diseño de ensayos clínicos para la atrofia geográfica debido a una degeneración macular asociada a la edad.
AR095118A1 (es) Un procedimiento de inactivación viral en composición que comprende factor vii
AR110185A1 (es) Método para promover los efectos de crecimiento de las plantas
UA105291U (uk) Спосіб передпосівної обробки проб біоматеріалу при культуральному дослідженні на туберкульоз